Supporting this, Sh2b1-deficient animals develop obesity and metabolic syndrome [50–53], while humans with SH2B1 loss-of-function mutations present with hyperphagia, childhood-onset obesity, disproportionate insulin resistance, and reduced adult height [54]. Here, SH2B1 is linked to obesity disorder.